Blind Cross-Site Scripting Vulnerability in Zkteco BioTime by ZKTeco
CVE-2022-38801

5.4MEDIUM

Key Information:

Vendor

Zkteco

Status
Biotime
Vendor
CVE Published:
30 November 2022

What is CVE-2022-38801?

The Zkteco BioTime software versions before 8.5.3 Build 20200816.447 are susceptible to a blind cross-site scripting vulnerability. This flaw allows an attacker to exploit the application by hijacking an administrator session and manipulating cookies, which can lead to unauthorized access and potential data compromise. It's crucial for organizations using this software to apply necessary updates and review their security practices to mitigate this risk.

References

https://www.zkteco.com/
https://gist.github.com/hamoshwani/5ac860dd6757440174f446...

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

.
CVE-2022-38801 : Blind Cross-Site Scripting Vulnerability in Zkteco BioTime by ZKTeco